Medical Oncologist
CION Cancer Clinics
What MSI-high status means for your colon cancer outlook | CION Cancer Clinics
MSI-high means the tumour's DNA repair system is not working. In early colon cancer this is usually reassuring, because these tumours tend to come back less often. In cancer that has spread, it means immunotherapy may work well. This page explains what the result changes at each stage, how it is tested, and when it raises a question for your family. At CION Cancer Clinics, our team goes through your reports with you and plans the next test or treatment step.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Is MSI-high good or bad news for my outlook?
- What does MSI-high change at each stage?
- How is MSI status tested, and what follows a positive result?
- What do MSS, dMMR and the other short forms mean?
- Four things families assume about MSI-high
- What this page cannot tell you
- Common questions about MSI-high colon cancer
The short answer
Is MSI-high good or bad news for my outlook?
In early colon cancer, MSI-high is usually reassuring news. As a group, MSI-high tumours at stage 2 are less likely to come back than other tumours of the same stage. In cancer that has spread, MSI-high matters for a different reason: it means immunotherapy may work, often better than chemotherapy.
What the letters mean
MSI stands for microsatellite instability. Every cell has a repair system, called mismatch repair or MMR, that fixes copying mistakes in DNA. When that system is broken, mistakes pile up in short repeated stretches of DNA called microsatellites. A tumour with many such mistakes is called MSI-high. Your report may say dMMR instead, meaning MMR-deficient. For practical purposes the two mean the same thing.
Why it changes the picture
A tumour full of DNA mistakes makes many abnormal proteins. The immune system notices them more easily. That is the likely reason MSI-high tumours often behave better early on, and why drugs that release the brakes on the immune system can work so well later.
MSI-high describes a group of tumours. It cannot predict what will happen to one person.Stage by stage
What does MSI-high change at each stage?
The same result means different things depending on how far the cancer has gone. Your tumour board reads it against your stage.
Stage 2
The outlook is generally favourable, and fluorouracil chemotherapy on its own appears to add little. Many people are advised no chemotherapy. If there are other warning features, such as a tumour that has grown through the bowel wall, it may still be discussed. Our page on the stage 2 chemotherapy dilemma explains how.
Stage 3
Once cancer is in the lymph nodes, the advantage is smaller. Chemotherapy after surgery is still recommended. Adding immunotherapy after surgery is being studied, so ask whether it applies to you.
Stage 4
MSI-high is uncommon once cancer has spread, but finding it matters most here. Immunotherapy is now a standard first choice, and some people stay on a good response for a long time.
Read more
Before surgery
In trials, immunotherapy given before an operation has shrunk many MSI-high colon cancers dramatically. It is not yet standard care everywhere, and the tumour board decides whether it is suitable.
Not sure whether this applies to you?
Ask an oncologistHow the result is reached
How is MSI status tested, and what follows a positive result?
Tumour tissue is tested
Every colon cancer should be tested, whatever the age, which is why it is called universal MMR testing. The partner laboratory uses the biopsy or the operation specimen. No extra procedure is needed.
One of two methods
A stain checks whether the four repair proteins are present, or a DNA test looks for the mistakes directly. Either method can give the answer. The details are on our page about MMR and MSI testing.
A follow-up check for one protein
If the protein called MLH1 is missing, the laboratory often checks for a BRAF change or a switched-off MLH1 gene. Either finding usually means the cause arose in the tumour alone.
A blood test, if needed
If those checks do not explain the result, a blood test for inherited faults is offered, ideally after genetic counselling.
On your report
What do MSS, dMMR and the other short forms mean?
- MSI-high or MSI-H
- Many copying mistakes were found in the tumour's DNA. The repair system inside the tumour is not working.
- MSS
- Microsatellite stable. No pile-up of mistakes was found, so the repair system works. Most colon cancers are MSS.
- dMMR
- Mismatch repair deficient. At least one of the four repair proteins was missing on the stain.
- pMMR
- Mismatch repair proficient. All four repair proteins were present, which usually goes with an MSS result.
- MLH1, MSH2, MSH6, PMS2
- The names of the four repair proteins. The report lists each one as retained, meaning present, or lost, meaning missing.
- MLH1 methylation
- The MLH1 gene was switched off inside the tumour alone. This points away from an inherited cause.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
Four things families assume about MSI-high
"MSI-high means the cancer runs in our family."
Usually it does not. Most MSI-high colon cancers arise in the tumour alone, more often in older people and on the right side of the colon. A minority are caused by Lynch syndrome, an inherited condition, and testing tells the two apart.
"MSI-high means I will not need chemotherapy."
Only in some stage 2 cancers. In stage 3, chemotherapy after surgery is still advised. The result changes the conversation, not every answer.
"If I am MSI-high, immunotherapy will definitely work."
It works for many, not all. Some tumours do not respond, and the side effects can be serious. Your oncologist will watch the response on scans.
"A good result means follow-up does not matter."
Follow-up matters just as much. A lower risk as a group still means some people have a recurrence, and finding it early keeps more choices open.
Being straight with you
What this page cannot tell you
It cannot tell you your own outlook. MSI status is one result among many. Stage, lymph node findings, budding, grade, your age and other illnesses all count, and only someone holding your full reports can weigh them together.
Who this does not apply to
If your report says MSS or pMMR, meaning the repair system works, most of this page does not apply, and immunotherapy alone is rarely used. If your cancer is in the rectum, MSI-high is tested the same way but the treatment path differs, so read our rectal cancer pages. If you have Lynch syndrome but no cancer, this page is about a tumour result, not about you.
Who can answer it
At CION, the tumour board reviews MSI status with your scans and pathology before a plan is confirmed. Immunotherapy, when it is advised, is given at CION centres. Testing is done by the partner laboratory that holds your tissue, and genetic counselling can be arranged if the result points to the family.
Questions we are asked
Common questions about MSI-high colon cancer
Is MSI-high the same as dMMR?
Almost always, yes. dMMR means the repair proteins are missing on a stain. MSI-high means the DNA mistakes they leave behind were found. They are two ways of seeing the same fault, and doctors treat either result the same way when planning treatment.
Does MSI-high mean my cancer is less serious?
In early-stage cancer, MSI-high tumours tend to come back less often than others of the same stage. That is an average across many people. It does not make your cancer minor, and it does not replace treatment or follow-up.
Will I be offered immunotherapy straight away?
That depends on stage. For cancer that has spread, immunotherapy is often the first treatment offered. For stage 2 and 3, surgery usually comes first, and immunotherapy before surgery is still mostly given in trials. The tumour board makes that call.
Should my brothers, sisters and children be tested?
Only if the follow-up checks suggest an inherited cause. If Lynch syndrome is confirmed in you, relatives can be tested for that exact fault. Our page on what an MMR-deficient result means for your family explains the steps.
Can MSI status change over time?
Very rarely. The repair fault is usually present from early in the tumour's life and stays. If your first test was unclear or failed, repeating it on another sample is reasonable. A recurrence is not normally retested unless the result would change treatment.
Is MSI-high common in India?
It is found in a minority of colon cancers everywhere, more often at early stages. Indian data are limited, which is one reason every colon cancer should be tested. Without the test, nobody can tell your status from symptoms, age or scans.
My report shows MSI-high and a BRAF change. Is that worse?
In early-stage cancer, the BRAF change mainly tells the laboratory the fault is probably not inherited. In cancer that has spread, it can affect drug choices. Your oncologist reads both results together rather than one against the other.
Can CION explain my MSI result?
Yes. Bring your pathology report, any MMR or MSI test report and your scan reports to a consultation or second opinion. An oncologist will explain what the result means for your stage. Call the helpline if you are unsure what to bring.
Your Specialists
Meet CION's colon cancer specialists. Bring your colonoscopy, scan or biopsy report.
Our surgical and medical oncologists plan colon cancer care together: which operation, whether chemotherapy is needed, and the follow-up that comes after.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Colon Cancer Treatment (PDQ), Health Professional Version
- American Cancer Society — Immunotherapy for Colorectal Cancer
- NICE — Molecular testing strategies for Lynch syndrome in people with colorectal cancer
- National Cancer Institute — Cancer Prognosis
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Universal MMR and MSI testingWhy every colon cancer is tested, whatever your ageWhen immunotherapy is an option in colon cancerWho is offered it, and at which point in treatmentWhat an MMR-deficient result means for your familyThe steps that decide whether relatives need testingTumour budding and newer prognostic markersThe other report findings that shape the outlook
Talk to us
Not sure what your MSI result means for your plan?
Share your pathology and MSI or MMR reports, and an oncologist will explain how the result fits your stage and your treatment choices. One helpline serves every CION centre.